Copyright
©2014 Baishideng Publishing Group Inc.
World J Gastroenterol. Nov 21, 2014; 20(43): 16293-16299
Published online Nov 21, 2014. doi: 10.3748/wjg.v20.i43.16293
Published online Nov 21, 2014. doi: 10.3748/wjg.v20.i43.16293
ROME III cohort (n = 100) | ROME II cohort (n = 160) | ||
With 6-mo requirement | With 3-mo requirement | Present 3 mo or more | |
Region | |||
A: Functional Esophageal Disorders | 34% | 55% | 40% |
B: Functional Gastroduodenal Disorders | 62% | 79% | 16% |
Without cyclic vomiting | 45% | 60% | |
C: Functional Bowel Disorders | 77% | 98% | 88% |
Without unspecified bowel disease | 53% | 80% | |
D: Functional Abdominal Pain Syndrome | 3% | 6% | 4% |
E: Functional Gallbladder and Sphincter of Oddi Disorders | 0% | 2% | |
F: Functional Anorectal Disorders1 | 16% | 20% | 35% |
Total | |||
At least one FGID | 83% | 94% | |
At least 3 FGIDs | 34% | 36% |
- Citation: Wang X, Luscombe GM, Boyd C, Kellow J, Abraham S. Functional gastrointestinal disorders in eating disorder patients: Altered distribution and predictors using ROME III compared to ROME II criteria. World J Gastroenterol 2014; 20(43): 16293-16299
- URL: https://www.wjgnet.com/1007-9327/full/v20/i43/16293.htm
- DOI: https://dx.doi.org/10.3748/wjg.v20.i43.16293